 Connection
John Rumsfeld to Acute Coronary Syndrome
This is a "connection" page, showing publications John Rumsfeld has written about Acute Coronary Syndrome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.585 |
|
|
|
-
Maddox TM, Tang F, Downs JR, Masoudi FA, Virani SS, Daugherty SL, Rumsfeld JS. Applicability of the IMPROVE-IT Trial to Current Patients With Acute Coronary Syndrome: An NCDR Research to Practice Project. JAMA Intern Med. 2017 06 01; 177(6):887-889.
Score: 0.434
-
Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, Rumsfeld JS. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009 Mar 04; 301(9):937-44.
Score: 0.245
-
Ho PM, Peterson ED, Wang L, Magid DJ, Fihn SD, Larsen GC, Jesse RA, Rumsfeld JS. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA. 2008 Feb 06; 299(5):532-9.
Score: 0.228
-
Plomondon ME, Ho PM, Wang L, Greiner GT, Shore JH, Sakai JT, Fihn SD, Rumsfeld JS. Severe mental illness and mortality of hospitalized ACS patients in the VHA. BMC Health Serv Res. 2007 Sep 18; 7:146.
Score: 0.222
-
Virani SS, Akeroyd JM, Nambi V, Maddox TM, Gillette MA, Michael Ho P, Rumsfeld J, Petersen LA, Ballantyne CM. Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria. Am J Med. 2015 Nov; 128(11):1253-6.
Score: 0.095
-
Ho PM, O'Donnell CI, Bradley SM, Grunwald GK, Helfrich C, Chapko M, Liu CF, Maddox TM, Tsai TT, Jesse RL, Fihn SD, Rumsfeld JS. 1-year risk-adjusted mortality and costs of percutaneous coronary intervention in the Veterans Health Administration: insights from the VA CART Program. J Am Coll Cardiol. 2015 Jan 27; 65(3):236-42.
Score: 0.092
-
Ho PM, Tsai TT, Wang TY, Shetterly SM, Clarke CL, Go AS, Sedrakyan A, Rumsfeld JS, Peterson ED, Magid DJ. Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):303-8.
Score: 0.066
-
Melloni C, Alexander KP, Ou FS, LaPointe NM, Roe MT, Newby LK, Baloch K, Ho PM, Rumsfeld JS, Peterson ED. Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome. Am J Cardiol. 2009 Jul 15; 104(2):175-81.
Score: 0.062
-
Aggarwal A, Dai D, Rumsfeld JS, Klein LW, Roe MT. Incidence and predictors of stroke associated with percutaneous coronary intervention. Am J Cardiol. 2009 Aug 01; 104(3):349-53.
Score: 0.062
-
Rao SV, Ou FS, Wang TY, Roe MT, Brindis R, Rumsfeld JS, Peterson ED. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2008 Aug; 1(4):379-86.
Score: 0.059
-
Curtis JP, Geary LL, Wang Y, Chen J, Drye EE, Grosso LM, Spertus JA, Rumsfeld JS, Weintraub WS, Masoudi FA, Brindis RG, Krumholz HM. Development of 2 registry-based risk models suitable for characterizing hospital performance on 30-day all-cause mortality rates among patients undergoing percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):628-37.
Score: 0.020
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|